{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:27:13Z","timestamp":1762475233003,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jdcr.2020.10.008","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T05:01:35Z","timestamp":1602306095000},"page":"1211-1213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oral tacrolimus for severe recalcitrant eosinophilic cellulitis"],"prefix":"10.1016","volume":"6","author":[{"given":"Mirmovich","family":"Morvay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuven","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Avitan-Hersh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2020.10.008_bib1","first-page":"46","article-title":"Recurrent granulomatous dermatitis with eosinophilia","volume":"57","author":"Wells","year":"1971","journal-title":"Trans St Johns Hosp Dermatol Soc"},{"issue":"9","key":"10.1016\/j.jdcr.2020.10.008_bib2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/jdv.13706","article-title":"Treatment of eosinophilic cellulitis (Wells syndrome) - a systematic review","volume":"30","author":"R\u00e4\u00dfler","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.jdcr.2020.10.008_bib3","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2165\/00003495-200363120-00006","article-title":"Tacrolimus: a further update of its use in the management of organ transplantation","volume":"63","author":"Scott","year":"2003","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.jdcr.2020.10.008_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1529-8019.2007.00137.x","article-title":"Systemic ciclosporin and tacrolimus in dermatology","volume":"20","author":"Madan","year":"2007","journal-title":"Dermatol Ther"},{"issue":"8","key":"10.1016\/j.jdcr.2020.10.008_bib5","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1111\/j.1365-2230.2009.03270.x","article-title":"Oral tacrolimus treatment for refractory eosinophilic cellulitis","volume":"34","author":"Ohtsuka","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.jdcr.2020.10.008_bib6","first-page":"989","article-title":"Wells syndrome","volume":"14","author":"Weins","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"10.1016\/j.jdcr.2020.10.008_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/229255031202000204","article-title":"Diagnosis and management of eosinophilic cellulitis (Wells' syndrome): a case series and literature review","volume":"20","author":"Sinno","year":"2012","journal-title":"Can J Plast Surg"},{"issue":"3","key":"10.1016\/j.jdcr.2020.10.008_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/0378-6323.95468","article-title":"Idiopathic bullous eosinophilic cellulitis (Wells syndrome) responsive to topical tacrolimus and antihistamine combination","volume":"78","author":"Verma","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"10.1016\/j.jdcr.2020.10.008_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1165\/ajrcmb.17.2.2819","article-title":"Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription","volume":"17","author":"Rolfe","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.jdcr.2020.10.008_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jdcr.2018.02.011","article-title":"Eosinophilic cellulitis (Wells syndrome) successfully treated with mepolizumab","volume":"4","author":"Herout","year":"2018","journal-title":"JAAD Case Rep"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620307323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620307323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:22:26Z","timestamp":1762474946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512620307323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2352512620307323"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.10.008","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral tacrolimus for severe recalcitrant eosinophilic cellulitis","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}